This is both a useful tool for giving us a better understanding of the genetic and
epigenetic program controlling the self - renewal of stem cells, and on a practical side, it could allow us to inexpensively produce large numbers of immune cells, which could then be used for regenerative medicine or immune therapy.»
Joining forces with dermatologists and oncologists from the University Hospital in Zurich and backed by the University Research Priority
Program «Translational Cancer Research,» Sommer's team was able to demonstrate that, in melanoma cells, the
epigenetic factor EZH2
controls genes that govern tumor growth as well as genes that are important for the formation of metastases.